Inicio>>Signaling Pathways>> Others>>Fodipir (DPDP)

Fodipir (DPDP)

Catalog No.GC31992

Fodipir (DPDP) es un metabolito activo de mangafodipir, implicado en la citoprotecciÓn mediada por mangafodipir contra la muerte celular inducida por &77#946;-hidroxicolesterol.

Products are for research use only. Not for human use. We do not sell to patients.

Fodipir (DPDP) Chemical Structure

Cas No.: 118248-91-2

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL Water)
79,00 $
Disponible
5mg
45,00 $
Disponible
10mg
72,00 $
Disponible
25mg
144,00 $
Disponible
50mg
252,00 $
Disponible
100mg
432,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Fodipir is an active metabolite of mangafodipir, involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death.

Fodipir is an active metabolite of mangafodipir, involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death. Fodipir (Dp-dp; Dipyridoxyl diphosphate; 100 μM) shows the best cytopretective effect on 7β-OH-mediated cell death after treatment for 8 h. Fodipir also reduces 7β-OH-induced cellular ROS production and lysosomal membrane permeabilization (LMP)[1].

[1]. Laskar A, et al. Fodipir and its dephosphorylated derivative dipyridoxyl ethyldiamine are involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death. Pharmacology. 2013;92(3-4):182-6.

Reseñas

Review for Fodipir (DPDP)

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fodipir (DPDP)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.